CHORUS AVIATION INC (CHR.CA) Fundamental Analysis & Valuation

TSX:CHR • CA17040T8885

23.81 CAD
-0.29 (-1.2%)
Last: Mar 4, 2026, 07:00 PM

This CHR.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

CHR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 6 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR get a neutral evaluation. Nothing too spectacular is happening here. CHR has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. CHR.CA Profitability Analysis

1.1 Basic Checks

  • In the past year CHR was profitable.
  • In the past year CHR had a positive cash flow from operations.
  • In multiple years CHR reported negative net income over the last 5 years.
  • CHR had a positive operating cash flow in 4 of the past 5 years.
CHR.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

  • CHR's Return On Assets of -2.62% is in line compared to the rest of the industry. CHR outperforms 50.00% of its industry peers.
  • The Return On Equity of CHR (-6.31%) is better than 66.67% of its industry peers.
  • CHR's Return On Invested Capital of 6.40% is amongst the best of the industry. CHR outperforms 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CHR is in line with the industry average of 4.97%.
  • The 3 year average ROIC (5.30%) for CHR is below the current ROIC(6.40%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROIC 6.4%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR.CA Yearly ROA, ROE, ROICCHR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

  • With an excellent Operating Margin value of 6.81%, CHR belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
  • CHR's Operating Margin has declined in the last couple of years.
  • With an excellent Gross Margin value of 65.68%, CHR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CHR has declined.
Industry RankSector Rank
OM 6.81%
PM (TTM) N/A
GM 65.68%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR.CA Yearly Profit, Operating, Gross MarginsCHR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

4

2. CHR.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHR is destroying value.
  • CHR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CHR.CA Yearly Shares OutstandingCHR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR.CA Yearly Total Debt VS Total AssetsCHR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 0.94, we must say that CHR is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of CHR (0.94) is comparable to the rest of the industry.
  • The Debt to FCF ratio of CHR is 10.63, which is on the high side as it means it would take CHR, 10.63 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 10.63, CHR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.50 indicates that CHR is somewhat dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.50, CHR belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Altman-Z 0.94
ROIC/WACC0.76
WACC8.39%
CHR.CA Yearly LT Debt VS Equity VS FCFCHR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

  • CHR has a Current Ratio of 1.22. This is a normal value and indicates that CHR is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.22, CHR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • A Quick Ratio of 0.63 indicates that CHR may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.63, CHR is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.63
CHR.CA Yearly Current Assets VS Current LiabilitesCHR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1

3. CHR.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 58.94% over the past year.
  • CHR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.51% yearly.
EPS 1Y (TTM)58.94%
EPS 3Y-9.92%
EPS 5Y-3.51%
EPS Q2Q%-5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-9.33%

3.2 Future

  • Based on estimates for the next years, CHR will show a decrease in Earnings Per Share. The EPS will decrease by -3.34% on average per year.
  • Based on estimates for the next years, CHR will show a decrease in Revenue. The Revenue will decrease by -2.14% on average per year.
EPS Next Y-16.67%
EPS Next 2Y-3.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.59%
Revenue Next 2Y-2.59%
Revenue Next 3Y-2.14%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
CHR.CA Yearly Revenue VS EstimatesCHR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CHR.CA Yearly EPS VS EstimatesCHR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

6

4. CHR.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 9.92 indicates a reasonable valuation of CHR.
  • Based on the Price/Earnings ratio, CHR is valued cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.74, CHR is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 11.91, the valuation of CHR can be described as very reasonable.
  • CHR's Price/Forward Earnings ratio is rather cheap when compared to the industry. CHR is cheaper than 83.33% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.82. CHR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.92
Fwd PE 11.91
CHR.CA Price Earnings VS Forward Price EarningsCHR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CHR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CHR is cheaper than 83.33% of the companies in the same industry.
  • CHR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CHR is cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.16
EV/EBITDA 4.16
CHR.CA Per share dataCHR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • A cheap valuation may be justified as CHR's earnings are expected to decrease with -3.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.34%
EPS Next 3YN/A

3

5. CHR.CA Dividend Analysis

5.1 Amount

  • CHR has a Yearly Dividend Yield of 1.43%. Purely for dividend investing, there may be better candidates out there.
  • CHR's Dividend Yield is a higher than the industry average which is at 0.90.
  • CHR's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.43%

5.2 History

  • On average, the dividend of CHR grows each year by 21.58%, which is quite nice.
  • CHR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
CHR.CA Yearly Dividends per shareCHR.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2025 2026 1 2 3

5.3 Sustainability

  • The earnings of CHR are negative and hence is the payout ratio. CHR will probably not be able to sustain this dividend level.
DP-5.89%
EPS Next 2Y-3.34%
EPS Next 3YN/A
CHR.CA Yearly Income VS Free CF VS DividendCHR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CHR.CA Fundamentals: All Metrics, Ratios and Statistics

CHORUS AVIATION INC

TSX:CHR (3/4/2026, 7:00:00 PM)

23.81

-0.29 (-1.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners3.74%
Inst Owner ChangeN/A
Ins Owners1.28%
Ins Owner ChangeN/A
Market Cap557.63M
Revenue(TTM)N/A
Net Income(TTM)-34.96M
Analysts78.18
Price Target31.18 (30.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.43%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-5.89%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)3.86%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)11.06%
Min EPS beat(4)3.86%
Max EPS beat(4)25.51%
EPS beat(8)6
Avg EPS beat(8)17.12%
EPS beat(12)6
Avg EPS beat(12)4.64%
EPS beat(16)8
Avg EPS beat(16)3.17%
Revenue beat(2)0
Avg Revenue beat(2)-6.2%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-4.09%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)2
Avg Revenue beat(8)-4.05%
Revenue beat(12)5
Avg Revenue beat(12)-1.79%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)2.39%
PT rev (3m)3.05%
EPS NQ rev (1m)0.52%
EPS NQ rev (3m)2.65%
EPS NY rev (1m)0%
EPS NY rev (3m)5.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.55%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-1.6%
Valuation
Industry RankSector Rank
PE 9.92
Fwd PE 11.91
P/S 0.41
P/FCF 17.16
P/OCF 7.83
P/B 1.01
P/tB 1.02
EV/EBITDA 4.16
EPS(TTM)2.4
EY10.08%
EPS(NY)2
Fwd EY8.4%
FCF(TTM)1.39
FCFY5.83%
OCF(TTM)3.04
OCFY12.77%
SpS57.62
BVpS23.67
TBVpS23.29
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.75
Profitability
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROCE 8.63%
ROIC 6.4%
ROICexc 6.56%
ROICexgc 6.62%
OM 6.81%
PM (TTM) N/A
GM 65.68%
FCFM 2.41%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Debt/EBITDA 1.32
Cap/Depr 32.58%
Cap/Sales 2.87%
Interest Coverage 2.74
Cash Conversion 33.79%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.63
Altman-Z 0.94
F-Score6
WACC8.39%
ROIC/WACC0.76
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.94%
EPS 3Y-9.92%
EPS 5Y-3.51%
EPS Q2Q%-5%
EPS Next Y-16.67%
EPS Next 2Y-3.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-9.33%
Revenue Next Year-4.59%
Revenue Next 2Y-2.59%
Revenue Next 3Y-2.14%
Revenue Next 5YN/A
EBIT growth 1Y-34.45%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year87.94%
EBIT Next 3Y16.24%
EBIT Next 5Y9.99%
FCF growth 1Y-89.3%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-80.17%
OCF growth 3Y12.73%
OCF growth 5Y0.25%

CHORUS AVIATION INC / CHR.CA FAQ

What is the fundamental rating for CHR stock?

ChartMill assigns a fundamental rating of 4 / 10 to CHR.CA.


Can you provide the valuation status for CHORUS AVIATION INC?

ChartMill assigns a valuation rating of 6 / 10 to CHORUS AVIATION INC (CHR.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for CHORUS AVIATION INC?

CHORUS AVIATION INC (CHR.CA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for CHR stock?

The Price/Earnings (PE) ratio for CHORUS AVIATION INC (CHR.CA) is 9.92 and the Price/Book (PB) ratio is 1.01.


How financially healthy is CHORUS AVIATION INC?

The financial health rating of CHORUS AVIATION INC (CHR.CA) is 4 / 10.